• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.47% Nasdaq Up0.39%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    7.49 Down 0.44(5.55%) 4:00PM EDT
    |After Hours : 7.65 Up 0.16 (2.14%) 7:41PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 53,834   31,479   17,382   19,052  
    Cost of Revenue14,806  11,689  8,705  9,956  
    Gross Profit 39,028   19,790   8,677   9,096  
    Operating Expenses
    Research Development2,334  290  346  969  
    Selling General and Administrative20,552  15,048  13,744  13,623  
    Non Recurring -   -  (6,457)6,457  
    Others18,680  10,159  1,969  2,190  
    Total Operating Expenses -   -  9,601  23,240  
    Operating Income or Loss (2,620) (5,701) (7,749) (14,144)
    Income from Continuing Operations
    Total Other Income/Expenses Net(82)6  (6,825) -  
    Earnings Before Interest And Taxes(2,620)(5,701)(7,749)(14,144)
    Interest Expense9,964  5,336  2,233  1,264  
    Income Before Tax(12,584)(11,036)(9,982)(15,408)
    Income Tax Expense(4,765)655  (3,749)(5,866)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,819)(11,691)(6,233)(9,542)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,819) (11,691) (6,233) (9,542)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,819) (11,691) (6,233) (9,542)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.